Other Articles

2021

2020
2019
2018
2017
2015
2014
2013
2012
2011
2009
All years

English

Swedish
All languages

News

Media Contact

Sarah Fredriksson

CEO

sarah.fredriksson@aqilion.com

+46 (0)70 261 4575

Share this page

Subscribe

Press releases (English)

Press releases (Swedish)

Read more about our Protection of your personal data.

About Aqilion

Aqilion is a biotech company that focuses on developing new innovative treatments for diseases caused by chronic inflammation and dysfunctional immune reactions such as autoimmune diseases. The company is mainly active in the early phases of drug discovery, from idea to early clinical development.

Aqilion combines its experience from major pharmaceutical companies with the drive and entrepreneurship of small growth companies. With solid experience of business development in innovative biotech and pharmaceutical companies, Aqilion’s experienced team and board have successfully shepherded drugs all the way from discovery to market.

AQILION AB (publ) is a Swedish public limited company headquartered in Helsingborg, Sweden.

Visiting address

AQILION AB

Henckels Torg 3

Helsingborg

Sweden

Postal address

AQILION AB

c/o HETCH AB

Redaregatan 48

SE-252 36 Helsingborg

Sweden

Cookie Policy
Privacy Policy